Previously treated cases tested for RR-/MDR-TB in Norway
Norway: Previously treated cases tested for RR-/MDR-TB was 100.0% in 2024. ▲ Rising
Latest (2024)
100.0%
Change on year
unchanged
World rank
1st
of 180 countries
All-time high
100.0%
in 2023
All-time low
29.0%
in 2017
Years of data
20
2005–2024
Previously treated cases tested for RR-/MDR-TB in Norway, 2005–2024
Source: World Health Organization, Global Health Observatory.
Analysis
Norway recorded 100.0% for previously treated cases tested for rr-/mdr-tb in 2024. That is the highest value across all 20 years on record.
That represents a change of up 37.0% over ten years.
Over the whole period, previously treated cases tested for rr-/mdr-tb in Norway peaked at 100.0% in 2023 and was at its lowest, 29.0%, in 2017.
That places Norway 1st out of 180 countries with data for 2024, putting it in the top 10%.
The long-run direction has been consistently rising across the 20 years of available data.
Previously treated cases tested for RR-/MDR-TB in Norway, year by year
| Year | Value | Change |
|---|---|---|
| 2005 | 57.0% | — |
| 2006 | 53.0% | -7.0% |
| 2007 | 71.0% | +34.0% |
| 2008 | 52.0% | -26.8% |
| 2009 | 67.0% | +28.8% |
| 2010 | 85.0% | +26.9% |
| 2011 | 65.0% | -23.5% |
| 2012 | 54.0% | -16.9% |
| 2013 | 44.0% | -18.5% |
| 2014 | 73.0% | +65.9% |
| 2015 | 53.0% | -27.4% |
| 2016 | 52.0% | -1.9% |
| 2017 | 29.0% | -44.2% |
| 2018 | 92.0% | +217.2% |
| 2019 | 78.0% | -15.2% |
| 2020 | 90.0% | +15.4% |
| 2021 | 90.0% | +0.0% |
| 2022 | 67.0% | -25.6% |
| 2023 | 100.0% | +49.3% |
| 2024 | 100.0% | +0.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 60.0% | 52.0% | 71.0% | 5 |
| 2010s | 62.5% | 29.0% | 92.0% | 10 |
| 2020s | 89.4% | 67.0% | 100.0% | 5 |
Countries ranked near Norway
- 1 Côte d'Ivoire 100.0% compare
- 1 Zambia 100.0% compare
- 1 Lithuania 100.0% compare
- 1 Slovenia 100.0% compare
- 1 Sri Lanka 100.0% compare
- 1 Bangladesh 100.0% compare
- 1 Fiji 100.0% compare
- 1 Kuwait 100.0% compare
- 1 Luxembourg 100.0% compare
- 1 Armenia 100.0% compare
- 1 Gambia 100.0% compare
- 1 Ghana 100.0% compare
- 1 Yemen 100.0% compare
- 1 Oman 100.0% compare
- 1 Brunei Darussalam 100.0% compare
- 1 Togo 100.0% compare
- 1 Israel 100.0% compare
- 1 Cameroon 100.0% compare
- 1 Jamaica 100.0% compare
- 1 Eritrea 100.0% compare
- 1 Cyprus 100.0% compare
- 1 Montenegro 100.0% compare
- 1 Sao Tome and Principe 100.0% compare
- 1 Viet Nam 100.0% compare
- 1 Belize 100.0% compare
- 1 Marshall Islands 100.0% compare
- 1 Republic of Moldova 100.0% compare
- 1 Comoros 100.0% compare
- 1 Kazakhstan 100.0% compare
- 1 Lao People's Democratic Republic 100.0% compare
- 1 Antigua and Barbuda 100.0% compare
- 1 Afghanistan 100.0% compare
- 1 Benin 100.0% compare
- 1 Jordan 100.0% compare
- 1 Puerto Rico 100.0% compare
- 1 Saint Vincent and the Grenadines 100.0% compare
- 1 Mauritius 100.0% compare
- 1 Congo 100.0% compare
- 1 Eswatini 100.0% compare
- 1 Micronesia, Federated States of 100.0% compare
- 1 Iceland 100.0% compare
- 1 Belarus 100.0% compare
- 1 Albania 100.0% compare
- 1 Mauritania 100.0% compare
- 1 Bhutan 100.0% compare
- 1 Tuvalu 100.0% compare
- 1 Malta 100.0% compare
- 1 Iraq 100.0% compare
- 1 Korea 100.0% compare
- 1 Papua New Guinea 100.0% compare
- 1 Bahamas 100.0% compare
- 1 Zimbabwe 100.0% compare
- 1 Andorra 100.0% compare
- 1 Turkmenistan 100.0% compare
More health data for Norway
- Un projection of annual infant deaths, annual growth rate -7.69 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.337 % change on previous year (2090)
- Heat deaths vs projected death rates 1,212 (2090)
- Un projection of annual infant deaths 12 (2100)
- Population ages 65 and above, female, annual growth rate 1.98 % change on previous year (2025)
- Population ages 65 and above, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 65 and above, female, per capita 0.1005 units per person (2025)
- Population ages 65 and above, male, annual growth rate 2.61 % change on previous year (2025)
- Population ages 65 and above, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 65 and above, male, per capita 0.0903 units per person (2025)
Frequently asked questions
- What is previously treated cases tested for rr-/mdr-tb in Norway?
- Previously treated cases tested for rr-/mdr-tb in Norway was 100.0% in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest previously treated cases tested for rr-/mdr-tb recorded in Norway?
- The highest recorded value was 100.0% in 2023.
- What is the lowest previously treated cases tested for rr-/mdr-tb recorded in Norway?
- The lowest recorded value was 29.0% in 2017.
- How does Norway rank for previously treated cases tested for rr-/mdr-tb?
- Norway ranks 1st out of 180 countries with data for 2024.
- Is previously treated cases tested for rr-/mdr-tb rising or falling in Norway?
- Over the last ten years it is up 37.0%. The long-run trend across the full record is rising.
- Where does this Norway data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Previously treated cases tested for RR-/MDR-TB (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 20 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).